# Nanoparticle Vaccine
פרקי פודקאסט מובילים
מְעוּדכָּן:
Top podcast episodes featuring nanoparticle vaccine.
TWiV 757: Supershedders and super vaccines
TWiV reveals that 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in a college campus, and a nanoparticle vaccine that induces cross-reactive immunity against multiple pandemic and pre-emergent coronaviruses.
Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Br…
TWiV 757: Supershedders and super vaccines
TWiV reveals that 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in a college campus, and a nanoparticle vaccine that induces cross-reactive immunity against multiple pandemic and pre-emergent coronaviruses.
Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Br…
TWiV 729: A floret of spikes with Matt Frieman
Matt Frieman returns to TWiV to discuss the COVID-19 pandemic from the point of view of a coronavirologist, including his work with Novavax on their spike protein-based vaccine.
Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, Kathy Spindler, and Brianne Barker
Guest: Matt Frieman
S…
TWiV 729: A floret of spikes with Matt Frieman
Matt Frieman returns to TWiV to discuss the COVID-19 pandemic from the point of view of a coronavirologist, including his work with Novavax on their spike protein-based vaccine.
Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, Kathy Spindler, and Brianne Barker
Guest: Matt Frieman
S…
Podcast 511: Ebola Treatment
Author: Rachel Beham, PharmD
Educational Pearls:
There are currently many Ebola vaccines that are being studied, and one (recombinant VZV-Ebola vaccine) is currently being used in Africa. This vaccine has so far shown good efficacy in reducing Ebola infections and mortality from Ebola in those…
Nanoparticle Vaccine Immunizes Against All Variants
Vidcast: https://youtu.be/R2F2OSytgGI
A new nanoparticle-based vaccine stimulates protective antibodies to the British, South African, and Brazilian variants in addition to the original Chinese CoVid. Immunologists from San Diego’s Scripps Research Institute and Philadelphia’s Temple Univ…
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
What does the evidence say on the safety and immunogenicity of the new Novavax vaccine for the SARS-CoV-2 infection?
127: E. coli and Burkholderia vaccines with Alfredo Torres
Pathogenic E. coli are different than lab-grown or commensal E. coli found in the gut microbiome. Alfredo Torres describes the difference between these, the method his lab is using the develop vaccines against pathogenic E. coli, and how this same method can be used to develop vaccines against Bur…
Novavax CoVid Vaccine Ties With mRNA Vaccines
Vidcast: https://youtu.be/u_XW1QD_308
Novavax, a nanoparticle complexed with a CoVid spike protein, is overall 89.7% effective. This is similar to the Modern and Pfizer vaccines and about 20% better than the adenovirus vector J&J and Astrazeneca vaccines. These results of a phase 3 study…
מנוע חיפוש PODCAST
אתה יכול להשתמש באתר שלנו כדי לחפש3,821,235פודקאסטים ופודקאסטים195,346,908לפי אנשים, מקומות או נושאים.
השקעה בידע מניבה את התשואה הטובה ביותר, ולכן אני מאזין לפודקאסטים.
‐ Benjamin "Llamacorn" Franklin
